Management and Treatment of Pulmonary Embolism: Alpha to Omega-Trials and Tribulations: Present and Future Trials in PE

Video Transcription

Video Summary

The speaker discusses various studies and trials related to thrombectomy devices used in the treatment of pulmonary embolism (PE). They mention ongoing and completed single-arm device trials, highlighting the importance of understanding bleeding risks and the limited sample size of some of these trials. The speaker also emphasizes the need for control groups and clinical outcome data to evaluate the effectiveness of these devices compared to standard anticoagulant treatments. They mention two trials, HiPytho and PE-TRACT, which aim to address these gaps in knowledge and provide important insights into the efficacy and long-term outcomes of catheter-directed therapy for PE patients. The PE-TRACT trial is particularly highlighted as the most important trial currently underway. The speaker encourages support for the trial and emphasizes its relevance for both interventional cardiologists and non-interventionalists. The transcript does not provide any information about the speaker, whether any credits were granted, or the source of the video.

Asset Subtitle

Akhilesh Sista, MD

Keywords

thrombectomy devices

pulmonary embolism

device trials

bleeding risks

catheter-directed therapy